Sebela Pharmaceuticals is committed to improving patients’ lives by developing, marketing and selling differentiated branded prescription pharmaceuticals for patients whose needs are not adequately satisfied. Sebela Pharmaceutical’s commercial activities are focused in the United States for niche therapeutic markets including gastroenterology, dermatology and women’s health.
To fulfill our commitment to improving patient’s lives, we are continuing to grow our US commercial infrastructure, marketed product portfolio and late stage development pipeline in our core therapeutic areas. Our growth strategy includes in-licensing and acquiring late-stage drug candidates and marketed products that utilize and enhance our existing development and commercial capabilities.
Sebela Pharmaceuticals operates from two locations with an office in Roswell, Georgia, and headquarters in Dublin, Ireland.